Your browser doesn't support javascript.
loading
CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations.
Tang, Ling; Huang, Hongming; Tang, Yutong; Li, Qing; Wang, Jue; Li, Dengju; Zhong, Zhaodong; Zou, Ping; You, Yong; Cao, Yang; Kong, Yingjie; Guo, Anyuan; Zhou, Shu; Li, Huimin; Meng, Fankai; Xiao, Yi; Zhu, Xiaojian.
Afiliación
  • Tang L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang H; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Tang Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li Q; Department of Hematology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhong Z; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zou P; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • You Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Kong Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Guo A; Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
  • Zhou S; Department of Hematology, Zhongnan Hospital Affiliated to Wuhan University, Wuhan, China.
  • Li H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Meng F; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Clin Transl Med ; 12(9): e1043, 2022 09.
Article en En | MEDLINE | ID: mdl-36163632

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Clin Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Clin Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China